Back to search results

Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.

Abroad (travel likely)RecruitingPHASE3

Conditions

Ocular Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Centre Hospitalier Universitaire De Bordeaux, Bordeaux, France

    Contact: Study coordinator (Dr Guilhem Sole) · guilhem.sole@chu-bordeaux.fr · +33557821380
    Contact: Principal Investigator (Dr Guilhem Sole)

  • Hôpital Raymond Pointcarre, Garches, France

    Contact: Study coordinator (Dr Edouard Berling) · edouard.berling@aphp.fr · +33147107900
    Contact: Principal Investigator (Dr Edouard Berling)

  • Centre Hospitalier Universitaire De Lille, Lille, France

    Contact: Study coordinator (Dr Céline Tard) · celine.tard@chru-lille.fr · +33320444145
    Contact: Principal Investigator (Dr Céline Tard)

  • Hospices Civils De Lyon, Lyon, France

    Contact: Study coordinator (Pr Caroline Froment) · caroline.froment01@chu-lyon.fr · +33472118012
    Contact: Principal Investigator (Pr Caroline Froment)

  • Centre Hospitalier Universitaire De Nice, Nice, France

    Contact: Study coordinator (Dr Saskia Bresch) · bresch.s@chu-nice.fr · +33492038173
    Contact: Principal Investigator (Dr Saskia Bresch)

  • CHNO, Paris, France

  • Hôpital de la Pitié-Salpêtrière, Paris, France

    Contact: Study coordinator (Dr Sophie Demeret) · sophie.demeret@aphp.fr · +33142161831
    Contact: Principal Investigator (Dr Sophie Demeret)

  • Centre Hospitalier Sainte Anne, Paris, France

  • Fondation Adolphe de Rothschild, Paris, France

    Contact: Study coordinator (Dr Antoine Gueguen) · agueguen@for.paris · +33148036755
    Contact: Principal Investigator (Dr Antoine Gueguen)

  • Les Hopitaux Universitaires De Strasbourg, Strasbourg, France

    Contact: Study coordinator (Dr Aleksandra Nadaj-Pakleza) · Aleksandra.Nadaj-Pakleza@chru-strasbourg.fr · +33388128556
    Contact: Principal Investigator (Dr Aleksandra Nadaj-Pakleza)

  • Centre Hospitalier Universitaire De Toulouse, Toulouse, France

View source on ClinicalTrials.gov(opens in a new tab)